Literature DB >> 22988866

The GTPase function of LRRK2.

Jean-Marc Taymans1.   

Abstract

LRRK2 (leucine-rich repeat kinase 2) is a large protein encoding multiple functional domains, including two catalytically active domains, a kinase and a GTPase domain. The LRRK2 GTPase belongs to the Ras-GTPase superfamily of GTPases, more specifically to the ROC (Ras of complex proteins) subfamily. Studies with recombinant LRRK2 protein purified from eukaryotic cells have confirmed that LRRK2 binds guanine nucleotides and catalyses the hydrolysis of GTP to GDP. LRRK2 is linked to PD (Parkinson's disease) and GTPase activity is impaired for several PD mutants located in the ROC and COR (C-terminal of ROC) domains, indicating that it is involved in PD pathogenesis. Ras family GTPases are known to function as molecular switches, and several studies have explored this possibility for LRRK2. These studies show that there is interplay between the LRRK2 GTPase function and its kinase function, with most data pointing towards a role for the kinase domain as an upstream regulator of ROC. The GTPase function is therefore a pivotal functionality within the LRRK2-mediated signalling cascade which includes partners encoded by other LRRK2 domains as well as other cellular signalling partners. The present review examines what is known of the enzymatic properties of the LRRK2 GTPase, the interplay between ROC and other LRRK2 domains, and the interplay between ROC and other cellular proteins with the dual goal to understand how LRRK2 GTPase affects cellular functions and point to future research venues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988866     DOI: 10.1042/BST20120133

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  26 in total

1.  Association between Parkinson's disease and G2019S and R1441C mutations of the LRRK2 gene.

Authors:  Xiao-Xia Li; Qin Liao; Huan Xia; Xin-Ling Yang
Journal:  Exp Ther Med       Date:  2015-07-27       Impact factor: 2.447

2.  Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts.

Authors:  Giambattista Guaitoli; Francesco Raimondi; Bernd K Gilsbach; Yacob Gómez-Llorente; Egon Deyaert; Fabiana Renzi; Xianting Li; Adam Schaffner; Pravin Kumar Ankush Jagtap; Karsten Boldt; Felix von Zweydorf; Katja Gotthardt; Donald D Lorimer; Zhenyu Yue; Alex Burgin; Nebojsa Janjic; Michael Sattler; Wim Versées; Marius Ueffing; Iban Ubarretxena-Belandia; Arjan Kortholt; Christian Johannes Gloeckner
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-29       Impact factor: 11.205

Review 3.  Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications.

Authors:  Iakov N Rudenko; Mark R Cookson
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 4.  RhoGEFs in cell motility: novel links between Rgnef and focal adhesion kinase.

Authors:  N L G Miller; E G Kleinschmidt; D D Schlaepfer
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

Review 5.  The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.

Authors:  Rebekah G Langston; Iakov N Rudenko; Mark R Cookson
Journal:  Biochem J       Date:  2016-02-01       Impact factor: 3.857

Review 6.  Contribution of GTPase activity to LRRK2-associated Parkinson disease.

Authors:  Elpida Tsika; Darren J Moore
Journal:  Small GTPases       Date:  2013-06-10

Review 7.  The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease.

Authors:  Hardy J Rideout; Leonidas Stefanis
Journal:  Neurochem Res       Date:  2013-06-01       Impact factor: 3.996

8.  Genetic insights into sporadic Parkinson's disease pathogenesis.

Authors:  Chou Chai; Kah-Leong Lim
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

Review 9.  Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.

Authors:  Nicolas Dzamko; Jinxia Zhou; Yue Huang; Glenda M Halliday
Journal:  Front Mol Neurosci       Date:  2014-06-24       Impact factor: 5.639

10.  In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2.

Authors:  Renée Vancraenenbroeck; Joren De Raeymaecker; Evy Lobbestael; Fangye Gao; Marc De Maeyer; Arnout Voet; Veerle Baekelandt; Jean-Marc Taymans
Journal:  Front Mol Neurosci       Date:  2014-06-03       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.